ビフィドバクテリアは,アセテート生成を通じて腸病原性感染症から身を守ることができます
Shinji Fukuda1, Hidehiro Toh, Koji Hase
1Laboratory for Epithelial Immunobiology, RIKEN Research Center for Allergy and Immunology, 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama, Kanagawa 230-0045, Japan.
Nature
|January 29, 2011
まとめ
特定のBifidobacterium菌株は,アセテートを生成することによって,致命的なE. coli O157:H7感染からマウスを保護します. このアセテートは腸の防御を強化し,Shiga毒素の転位を阻害し,新しい治療戦略を提供します.
科学分野:
- マイクロバイオームの研究
- ホスト-病原体相互作用
- 免疫学 免疫学とは
背景:
- 人間の腸内微生物群,特にBifidobacterium種は,免疫調節と感染予防を含む健康上の利点をもたらします.
- これらの保護効果の背後にある正確な分子機構は,ほとんど不明のままである.
- エントロヘモラジックEscherichia coli O157:H7は,重要な感染症の脅威となっている.
研究 の 目的:
- ビフィドバクテリアの種が感染症から保護する分子メカニズムを解明する.
- E. coli O157:H7感染に対する宿主防御における特定の細菌遺伝子の役割を調査する.
主な方法:
- 特定のBifidobacterium菌株でコロニー化されたマウスモデルを使用しました.
- 腸出血性Escherichia coli O157:H7.7を用いた致死性の感染モデルを採用しました.
- 分子メカニズムを分析するための統合されたマルチオミックスのアプローチ.
主要な成果:
- ビフィドバクテリアのATP結合型カセット型炭水化物トランスポーターをコードする遺伝子を特定し,E. coli O157:H7による死亡率に対する保護に不可欠である.
- これらのバクテリアによるアセテート生成が,保護を与える重要な要因であることを実証した.
- 腸のから血流にシガ毒素の転位を阻害することが示された.
結論:
- 保護性の高いBifidobacterium菌株によって生成されるアセタートは,腸内上皮質細胞媒介による防御を強化する.
- このアセテート生産メカニズムは,宿主を致死性感染症から守るための新しい戦略を提供します.
- この発見は,細菌の病原体に対する微生物群媒介による保護に関する重要な洞察を提供します.
関連する概念動画
01:20Infection
When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
01:26Defense Mechanism Against Infection
Natural flora, body system defenses, and inflammation are natural barriers of the body against infectious agents regardless of previous exposure. Normal floras of the human body refer to the microbial population that colonizes the skin and mucous membranes.
In addition, many body organ systems have unique defenses against infection. The skin is an intact, multilayered surface preventing invasion by microorganisms unless impaired. Mucous membranes lining the mouth, nose, and eyelids are barriers...
In addition, many body organ systems have unique defenses against infection. The skin is an intact, multilayered surface preventing invasion by microorganisms unless impaired. Mucous membranes lining the mouth, nose, and eyelids are barriers...
01:18Dysbiosis of the Gut Microbiota
The human gut microbiome includes a diverse array of microbial species, including beneficial commensals and opportunistic pathogens, which interact to support host health. These microbes contribute to essential functions such as nutrient metabolism, immune system modulation, and maintenance of intestinal barrier integrity. However, disruptions to this equilibrium—referred to as dysbiosis—can have widespread physiological consequences.Dysbiosis is often characterized by reduced microbial...
01:21Microbiota Modulation by Antibiotics
Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
01:18Bacterial Gastroenteritis
Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
01:28Amebiasis
Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...